Hidradenitis Suppurativa: Defining Window of Opportunity for Moderate-to-Severe Patients

This special podcast episode, developed in collaboration with UCB, features LiVDerm faculty and esteemed dermatologists Dr. Jennifer Hsiao, MD, and Dr. Hadar Lev-Tov, MD. As experts in all things hidradenitis suppurativa (HS), our faculty discuss the need for early and accurate diagnosis and assessment of patients with HS in order to prescribe treatment at the best time to achieve disease control, including the following topics:

• Key challenges in treating patients with moderate-to-severe HS
• The role of targeted, systemic therapies in HS management
Defining "moderate" disease and strategies for severity assessment
Defining window of opportunity and strategies for advanced treatment of HS
Defining and assessing treatment response and success with targeted therapies